Exploring the Role of AI Companies in Revolutionizing Healthcare: A Case Study of Organon & Co. (NYSE: OGN)
In recent years, the healthcare and pharmaceutical industries have witnessed a remarkable transformation driven by advances in artificial intelligence (AI) and machine learning (ML) technologies. These innovations have the potential to enhance drug discovery, patient care, and overall healthcare management. One noteworthy player in this evolving landscape is Organon & Co. (NYSE: OGN). In this…